Can-Fite Biopharma Overview

Can-Fite Biopharma Operating Income

Operating Income for CANF.

Quarterly Operating Income

$-2449000.00

↑ 19.64% YoY

As of Jun 30, 2025

Annual Operating Income (TTM)

$-8934000.00

↑ 14.64% YoY

Trailing 12 months ending Jun 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin